| | |
| Clinical data | |
|---|---|
| Trade names | Akrinor, Bifort, Praxinor |
| Other names | Caphedrine; Cafedrin; Caphedrin; Kafedrin; Norephedrino-ethyltheophylline; 7-(2-(β-Hydroxy-α-methylphen-ethylamino)ethyl)theophylline |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C18H23N5O3 |
| Molar mass | 357.414 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Cafedrine (INN , BAN ), sold under the brand name Akrinor among others, is a chemical linkage of norephedrine and theophylline and is a cardiac stimulant and antihypotensive agent used to increase blood pressure in people with hypotension. [1] [2] [3] [4] It has been marketed in Europe, South Africa, and Indonesia. [4] [5]
There has been concern about cafedrine as a potential performance-enhancing drug and doping agent in sports. [6]
{{cite web}}: CS1 maint: bot: original URL status unknown (link)